Document is current

Any future updates will be listed below

A fractional-order model for optimizing combination therapy in heterogeneous lung cancer: integrating immunotherapy and targeted therapy to minimize side effects

Crossref DOI link: https://doi.org/10.1038/s41598-024-66531-x

Published Online: 2024-08-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark